ABVC BioPharma, Inc.
NASDAQ: ABVC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Uttam Yashwant Patil
- Employees
- 16
- Headquarters
- Fremont, United States
- IPO year
- 2004
- Market cap
- $19.3M
- Website
- https://www.abvcpharma.com
Loading ABVC…
Loading profile data…Frequently asked questions about ABVC
What does ABVC BioPharma, Inc. (ABVC) do?
ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on creating novel drugs and medical devices to address critical, underserved healthcare requirements across the United States. The company's pipeline includes several key candidates: ABV-1501, currently undergoing Phase I/II clinical trials, is being developed as a combin...
Where does ABVC trade?
ABVC BioPharma, Inc. (ABVC) trades on the NASDAQ Capital Market.
What sector is ABVC in?
ABVC BioPharma, Inc. (ABVC) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of ABVC BioPharma, Inc.?
Uttam Yashwant Patil is the chief executive officer of ABVC BioPharma, Inc. (ABVC).
Where is ABVC BioPharma, Inc. headquartered?
ABVC BioPharma, Inc. is headquartered in United States.
Does ABVC pay a dividend?
ABVC BioPharma, Inc. (ABVC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ABVC go public?
ABVC BioPharma, Inc. (ABVC) completed its initial public offering in 2004.